Von Willebrand factor in patients with coronary artery disease: Communication with cardiovascular risk factors

被引:0
|
作者
Golikova, IP [1 ]
Nemchyna, OO [1 ]
机构
[1] AMS Ukraine, Strazhesko Inst Cardiol, Kiev, Ukraine
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S396 / S396
页数:1
相关论文
共 50 条
  • [21] Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis
    Dzielinska, Zofia
    Januszewicz, Andrzej
    Demkow, Marcin
    Makowiecka-Ciesla, Magdalena
    Prejbisz, Aleksander
    Naruszewicz, Marek
    Nowicka, Grazyna
    Kadziela, Jacek
    Zielinski, Tomasz
    Florczak, Elzbieta
    Janas, Jadwiga
    Januszewicz, Magdalena
    Ruzyllo, Witold
    JOURNAL OF HYPERTENSION, 2007, 25 (03) : 663 - 670
  • [22] VON WILLEBRAND FACTOR AS A PREDICTOR OF RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMATURE CORONARY ATHEROSCLEROSIS
    Urazgildeeva, S. A.
    Alekseeva, I. V.
    Vasina, L. V.
    Grigoriev, S. G.
    Muzalevskaya, M. V.
    Baranova, E. V.
    Shurygina, V. D.
    ATHEROSCLEROSIS, 2022, 355 : E45 - E45
  • [23] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    HAEMOPHILIA, 2022, 28 : 11 - 17
  • [24] von Willebrand Factor and von Willebrand Disease
    王兆钺
    血栓与止血学, 2005, (04) : 147 - 149
  • [25] Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease
    Jin, Hong
    Chen, Yifei
    Wang, Bilei
    Zhu, Yi
    Chen, Long
    Han, Xiqiong
    Ma, Genshan
    Liu, Naifeng
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [26] Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease
    Hong Jin
    Yifei Chen
    Bilei Wang
    Yi Zhu
    Long Chen
    Xiqiong Han
    Genshan Ma
    Naifeng Liu
    BMC Cardiovascular Disorders, 18
  • [27] Cardiovascular disease risk factors in offspring of parents with coronary artery disease
    Tur, I
    Kurvinen, E
    Solodkaia, E
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (04) : 9 - 9
  • [28] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [29] Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease
    Ragni, Margaret V.
    Castaman, Giancarlo
    Gill, Joan Cox
    Kouides, Peter
    Chapman, Miranda
    Sytkowski, Arthur
    Obermann-Slupetzky, Ortrun
    Presch, Isabella
    Fritsch, Sandor
    Ewenstein, Bruce M.
    BLOOD, 2015, 126 (23)
  • [30] Association of cyclophilins and cardiovascular risk factors in coronary artery disease
    Gegunde, Sandra
    Alfonso, Amparo
    Alvarino, Rebeca
    Perez-Fuentes, Nadia
    Bayon-Lorenzo, Jeremias
    Alonso, Eva
    Ocaranza-Sanchez, Raymundo
    Abellas-Sequeiros, Rosa Alba
    Santas-Alvarez, Melisa
    Vieytes, Mercedes R.
    Juanatey-Gonzalez, Carlos
    Botana, Luis M.
    FRONTIERS IN PHYSIOLOGY, 2023, 14